The Female Preponderance to Cough Hypersensitivity Syndrome: Another Clue Pointing to the Role of TRPV1 in Cough by Kornelis W. Patberg
LETTER TO THE EDITOR
The Female Preponderance to Cough Hypersensitivity Syndrome:
Another Clue Pointing to the Role of TRPV1 in Cough
Kornelis W. Patberg
Received: 12 February 2011 / Accepted: 3 April 2011 / Published online: 21 April 2011
 The Author(s) 2011. This article is published with open access at Springerlink.com
In a recently published study by Morice et al. [1] cough
hypersensitivity syndrome (CHS) is put forward as a dis-
tinct disease entity, an exciting concept. Within their def-
inition, the lion’s share of patients referred to a specialized
cough clinic would fit the diagnosis of CHS (as assessed by
the newly presented Hull Airway Reflux Questionnaire
[1]). This single clinical entity includes several phenotypes
like rhinitis-dominant CHS or the predominantly Th2
response CHS (also known as cough-variant asthma).
However, the hypothesis is that a single precipitant pre-
disposes these patients to cough. The authors speculate that
this is a gaseous nonacid reflux that has been undetectable
thus far with the currently available techniques.
An alternative (or complementary) predisposing fac-
tor one could think of is upregulation of the receptor-
channel transient receptor potential vanilloid (TRPV) type
1. Morice et al. have done a vast amount of work exploring
the role of this ion channel in chronic cough and so have
others [2–4]. This channel has gained popularity as a
‘‘cough-mediating receptor’’ since it triggers afferent nerve
activity in response to cough-provoking stimuli, including
heat, acid, and certain arachidonic acid derivatives. The
channel is also indirectly activated by inflammatory
mediators like bradykinin, nerve growth factor, and pros-
taglandin [5]. Furthermore, TRPV1 expression is increased
in chronic coughers and the channel is upregulated in
reaction to inflammation [3, 4].
From the data presented in Morice et al., I think another
clue to the involvement of TRPV1 might be derived. As
shown before by others [6, 7], the study by Morice et al.
shows a female preponderance for developing CHS. Hitherto
this female predilection to CHS has not been elucidated.
However, the literature offers the ingredients for a plausible
hypothesis which is in line with a role for TRPV1 in CHS.
A female predominance for afflictions involving ion
channels is not unusual in nature. The influence of sex
hormones on ion channels has long been recognized,
explaining many pathogenic differences between men and
women. For example, women are at greater risk for drug-
induced cardiac arrhythmias, and the female gender itself is
an independent risk factor for sudden death. This is, at least
in part, explained by an effect of estrogen on mRNA levels
of several potassium and calcium channels (reviewed in
[8]). Estrogen also influences TRPV1 activation/sensitiza-
tion. Although some controversy exists, most studies
describe a gain of function. Not surprisingly, most reports
on this subject stem from the field of gynaecology and
describe the importance of the channel in activating afferent
nerve fibers in gynecologic pain. Yan et al. [9] show that in
ovariectomized rats TRPV1 becomes important only in
activating afferent nerve fibers in response to uterine cer-
vical distension after estrogen replacement therapy. Peng
et al. [10] show that the sensitization of TRPV1 as a noci-
ceptive activator of C fibers in rats is dependent on the
estrous cycle. Moreover, they demonstrated that capsaicin-
induced activation of C fibers is significantly greater in the
proestrus stage (high estradiol, low progesterone) than in
the metestrus stage (low estradiol, high progesterone),
favoring estradiol over progesterone as a hormonal media-
tor of TRPV1. Kiasalari et al. [11] identified a population of
C-fiber cells that express high levels of TRPV1 and more
than 75% of these cells express estrogen receptor a, sug-
gesting a role for estrogen in regulating these cells.
From the above, it is hypothesized that the influence of
estrogen on TRPV1 predisposes the female sex to CHS,
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thus explaining the higher prevalence of CHS among
women. This association would strengthen the hypothesis
that TRPV1 is important in CHS.
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